Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.

Spigel DR, Shipley DL, Waterhouse DM, Jones SF, Ward PJ, Shih KC, Hemphill B, McCleod M, Whorf RC, Page RD, Stilwill J, Mekhail T, Jacobs C, Burris HA 3rd, Hainsworth JD.

Oncologist. 2019 Aug 16. pii: theoncologist.2018-0518. doi: 10.1634/theoncologist.2018-0518. [Epub ahead of print]

PMID:
31420467
2.

The observation of vibrating pear-shapes in radon nuclei.

Butler PA, Gaffney LP, Spagnoletti P, Konki J, Scheck M, Smith JF, Abrahams K, Bowry M, Cederkäll J, Chupp T, de Angelis G, De Witte H, Garrett PE, Goldkuhle A, Henrich C, Illana A, Johnston K, Joss DT, Keatings JM, Kelly NA, Komorowska M, Kröll T, Lozano M, Nara Singh BS, O'Donnell D, Ojala J, Page RD, Pedersen LG, Raison C, Reiter P, Rodriguez JA, Rosiak D, Rothe S, Shneidman TM, Siebeck B, Seidlitz M, Sinclair J, Stryjczyk M, Van Duppen P, Vinals S, Virtanen V, Warr N, Wrzosek-Lipska K, Zielinska M.

Nat Commun. 2019 Jun 6;10(1):2473. doi: 10.1038/s41467-019-10494-5.

3.

Ozymandias: a biodiversity knowledge graph.

Page RDM.

PeerJ. 2019 Apr 8;7:e6739. doi: 10.7717/peerj.6739. eCollection 2019.

4.

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer.

Leighl NB, Page RD, Raymond VM, Daniel DB, Divers SG, Reckamp KL, Villalona-Calero MA, Dix D, Odegaard JI, Lanman RB, Papadimitrakopoulou VA.

Clin Cancer Res. 2019 Aug 1;25(15):4691-4700. doi: 10.1158/1078-0432.CCR-19-0624. Epub 2019 Apr 15.

PMID:
30988079
5.

Implementing an Electronic End-of-Life Chemotherapy Utilization Measure.

Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, Meropol NJ.

J Oncol Pract. 2019 Apr;15(4):220-223. doi: 10.1200/JOP.18.00408. Epub 2019 Mar 18. No abstract available.

PMID:
30883256
6.

Reducing Cancer Costs Through Symptom Management and Triage Pathways.

Barkley R, Soobader MJ, Wang J, Blau S, Page RD.

J Oncol Pract. 2019 Feb;15(2):e91-e97. doi: 10.1200/JOP.18.00082. Epub 2018 Dec 21.

PMID:
30576262
7.

First Accurate Normalization of the β-delayed α Decay of ^{16}N and Implications for the ^{12}C(α,γ)^{16}O Astrophysical Reaction Rate.

Kirsebom OS, Tengblad O, Lica R, Munch M, Riisager K, Fynbo HOU, Borge MJG, Madurga M, Marroquin I, Andreyev AN, Berry TA, Christensen ER, Fernández PD, Doherty DT, Van Duppen P, Fraile LM, Gallardo MC, Greenlees PT, Harkness-Brennan LJ, Hubbard N, Huyse M, Jensen JH, Johansson H, Jonson B, Judson DS, Konki J, Lazarus I, Lund MV, Marginean N, Marginean R, Perea A, Mihai C, Negret A, Page RD, Pucknell V, Rahkila P, Sorlin O, Sotty C, Swartz JA, Sørensen HB, Törnqvist H, Vedia V, Warr N, De Witte H.

Phys Rev Lett. 2018 Oct 5;121(14):142701. doi: 10.1103/PhysRevLett.121.142701.

PMID:
30339438
8.

Impact on Oncology Practices of Including Drug Costs in Bundled Payments.

Ward JC, Levit LA, Page RD, Hennessy JE, Cox JV, Kamin DY, Bruinooge SS, Shih YT, Polite BN.

J Oncol Pract. 2018 May;14(5):e259-e268. doi: 10.1200/JOP.17.00036. Epub 2018 Apr 12.

PMID:
29648923
9.

Oncology Clinical Pathways: Charting the Landscape of Pathway Providers.

Daly B, Zon RT, Page RD, Edge SB, Lyman GH, Green SR, Wollins DS, Bosserman LD.

J Oncol Pract. 2018 Mar;14(3):e194-e200. doi: 10.1200/JOP.17.00033. Epub 2018 Feb 7. No abstract available.

PMID:
29412768
10.

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.

Knox JJ, Barrios CH, Kim TM, Cosgriff T, Srimuninnimit V, Pittman K, Sabbatini R, Rha SY, Flaig TW, Page RD, Beck JT, Cheung F, Yadav S, Patel P, Geoffrois L, Niolat J, Berkowitz N, Marker M, Chen D, Motzer RJ.

Ann Oncol. 2018 Nov 1;29(11):2269. doi: 10.1093/annonc/mdx807. No abstract available.

11.

Financial Conflicts of Interest Among Oncology Clinical Pathway Vendors.

Daly B, Bach PB, Page RD.

JAMA Oncol. 2018 Feb 1;4(2):255-257. doi: 10.1001/jamaoncol.2017.4473. No abstract available.

12.

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy.

Thomas M, Spigel DR, Jotte RM, McCleod M, Socinski MA, Page RD, Gressot L, Knoble J, Juan O, Morgensztern D, Isla D, Kim ES, West H, Ko A, Ong TJ, Trunova N, Gridelli C.

Lung Cancer (Auckl). 2017 Oct 30;8:207-216. doi: 10.2147/LCTT.S138570. eCollection 2017.

13.

The Role of Proteomic Testing in Improving Prognosis And Care Planning Quality Measures for Lung Cancer.

Page RD, Argento AC, Nash DB, Skoufalos A, Schaefer ES.

Manag Care. 2017 Sep;26(9):37-47. Review.

14.

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.

Knox JJ, Barrios CH, Kim TM, Cosgriff T, Srimuninnimit V, Pittman K, Sabbatini R, Rha SY, Flaig TW, Page RD, Beck JT, Cheung F, Yadav S, Patel P, Geoffrois L, Niolat J, Berkowitz N, Marker M, Chen D, Motzer RJ.

Ann Oncol. 2017 Jun 1;28(6):1339-1345. doi: 10.1093/annonc/mdx075. Erratum in: Ann Oncol. 2018 Nov 1;29(11):2269.

15.

American Society of Clinical Oncology Criteria for High-Quality Clinical Pathways in Oncology.

Zon RT, Edge SB, Page RD, Frame JN, Lyman GH, Omel JL, Wollins DS, Green SR, Bosserman LD.

J Oncol Pract. 2017 Mar;13(3):207-210. doi: 10.1200/JOP.2016.019836. Epub 2017 Feb 7. No abstract available.

PMID:
28282276
16.

Impact of a multivariate serum-based proteomic test on physician treatment recommendations for advanced non-small-cell lung cancer.

Akerley WL, Arnaud AM, Reddy B, Page RD.

Curr Med Res Opin. 2017 Jun;33(6):1091-1097. doi: 10.1080/03007995.2017.1301903. Epub 2017 Mar 16.

PMID:
28277859
17.

Does neoadjuvant chemoradiotherapy increase survival in patients with resectable oesophageal cancer?

Buderi SI, Shackcloth M, Page RD.

Interact Cardiovasc Thorac Surg. 2017 Jan;24(1):115-120. doi: 10.1093/icvts/ivw281. Epub 2016 Sep 13. Review.

PMID:
27624359
18.

Risk factors for poor outcomes in patients with open-globe injuries.

Page RD, Gupta SK, Jenkins TL, Karcioglu ZA.

Clin Ophthalmol. 2016 Aug 1;10:1461-6. doi: 10.2147/OPTH.S108901. eCollection 2016.

19.

DNA barcoding and taxonomy: dark taxa and dark texts.

Page RD.

Philos Trans R Soc Lond B Biol Sci. 2016 Sep 5;371(1702). pii: 20150334. doi: 10.1098/rstb.2015.0334. Review.

20.

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.

Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MK, Rintoul RC, Screaton N, Wald NJ, Weller D, Whynes DK, Williamson PR, Yadegarfar G, Hansell DM.

Health Technol Assess. 2016 May;20(40):1-146. doi: 10.3310/hta20400.

21.

Surfacing the deep data of taxonomy.

Page RD.

Zookeys. 2016 Jan 7;(550):247-60. doi: 10.3897/zookeys.550.9293. eCollection 2016.

22.

Oncology Pathways-Preventing a Good Idea From Going Bad.

Polite BN, Page RD, Nabhan C.

JAMA Oncol. 2016 Mar;2(3):297-8. doi: 10.1001/jamaoncol.2015.5778. No abstract available.

PMID:
26847876
23.

American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.

Zon RT, Frame JN, Neuss MN, Page RD, Wollins DS, Stranne S, Bosserman LD.

J Oncol Pract. 2016 Mar;12(3):261-6. doi: 10.1200/JOP.2015.009134. Epub 2016 Jan 12.

PMID:
26759491
24.

Refining the Standard of Care: How Oncology Treatment Pathways Can Make a Difference.

Page RD.

J Oncol Pract. 2016 Feb;12(2):143-4. doi: 10.1200/JOP.2015.007872. Epub 2016 Jan 12. No abstract available.

PMID:
26759490
25.

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Field JK, Duffy SW, Baldwin DR, Whynes DK, Devaraj A, Brain KE, Eisen T, Gosney J, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MK, Rassl DM, Rintoul RC, Screaton NJ, Wald NJ, Weller D, Williamson PR, Yadegarfar G, Hansell DM.

Thorax. 2016 Feb;71(2):161-70. doi: 10.1136/thoraxjnl-2015-207140. Epub 2015 Dec 8.

26.

The patient-centered medical home in oncology: from concept to reality.

Page RD, Newcomer LN, Sprandio JD, McAneny BL.

Am Soc Clin Oncol Educ Book. 2015:e82-9. doi: 10.14694/EdBook_AM.2015.35.e82.

27.

Community next steps for making globally unique identifiers work for biocollections data.

Guralnick RP, Cellinese N, Deck J, Pyle RL, Kunze J, Penev L, Walls R, Hagedorn G, Agosti D, Wieczorek J, Catapano T, Page RD.

Zookeys. 2015 Apr 6;(494):133-54. doi: 10.3897/zookeys.494.9352. eCollection 2015.

28.

Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.

Hornberger J, Hirsch FR, Li Q, Page RD.

Lung Cancer. 2015 May;88(2):223-30. doi: 10.1016/j.lungcan.2015.03.006. Epub 2015 Mar 12.

PMID:
25804732
29.

Reply to a. Small et al.

Newcomer LN, Donelan SA, Perkins M, Gould B, Page RD.

J Oncol Pract. 2015 Mar;11(2):162. doi: 10.1200/JOP.2014.002071. Epub 2014 Dec 16. No abstract available.

PMID:
25515719
30.

Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.

Polite BN, Ward JC, Cox JV, Morton RF, Hennessy J, Page RD, Conti RM.

J Oncol Pract. 2014 Nov;10(6):357-62. doi: 10.1200/JOP.2014.001958. No abstract available.

31.

Hindered Gamow-Teller decay to the odd-odd N=Z (62)Ga: absence of proton-neutron T=0 condensate in A=62.

Grodner E, Gadea A, Sarriguren P, Lenzi SM, Grebosz J, Valiente-Dobón JJ, Algora A, Górska M, Regan PH, Rudolph D, de Angelis G, Agramunt J, Alkhomashi N, Amon Susam L, Bazzacco D, Benlliure J, Benzoni G, Boutachkov P, Bracco A, Caceres L, Cakirli RB, Crespi FC, Domingo-Pardo C, Doncel M, Dombrádi Z, Doornenbal P, Farnea E, Ganioğlu E, Gelletly W, Gerl J, Gottardo A, Hüyük T, Kurz N, Leoni S, Mengoni D, Molina F, Morales AI, Orlandi R, Oktem Y, Page RD, Perez D, Pietri S, Podolyák Z, Poves A, Quintana B, Rinta-Antila S, Rubio B, Nara Singh BS, Steer AN, Verma S, Wadsworth R, Wieland O, Wollersheim HJ.

Phys Rev Lett. 2014 Aug 29;113(9):092501. Epub 2014 Aug 28.

PMID:
25215980
32.

Changing physician incentives for affordable, quality cancer care: results of an episode payment model.

Newcomer LN, Gould B, Page RD, Donelan SA, Perkins M.

J Oncol Pract. 2014 Sep;10(5):322-6. doi: 10.1200/JOP.2014.001488. Epub 2014 Jul 8.

PMID:
25006221
33.

Reweaving the tapestry: a supertree of birds.

Davis KE, Page RD.

PLoS Curr. 2014 Jun 9;6. pii: ecurrents.tol.c1af68dda7c999ed9f1e4b2d2df7a08e. doi: 10.1371/currents.tol.c1af68dda7c999ed9f1e4b2d2df7a08e.

34.

Shape coexistence in the neutron-deficient even-even (182-188)Hg isotopes studied via coulomb excitation.

Bree N, Wrzosek-Lipska K, Petts A, Andreyev A, Bastin B, Bender M, Blazhev A, Bruyneel B, Butler PA, Butterworth J, Carpenter MP, Cederkäll J, Clément E, Cocolios TE, Deacon A, Diriken J, Ekström A, Fitzpatrick C, Fraile LM, Fransen Ch, Freeman SJ, Gaffney LP, García-Ramos JE, Geibel K, Gernhäuser R, Grahn T, Guttormsen M, Hadinia B, Hadyńska-Kle K K, Hass M, Heenen PH, Herzberg RD, Hess H, Heyde K, Huyse M, Ivanov O, Jenkins DG, Julin R, Kesteloot N, Kröll T, Krücken R, Larsen AC, Lutter R, Marley P, Napiorkowski PJ, Orlandi R, Page RD, Pakarinen J, Patronis N, Peura PJ, Piselli E, Rahkila P, Rapisarda E, Reiter P, Robinson AP, Scheck M, Siem S, Singh Chakkal K, Smith JF, Srebrny J, Stefanescu I, Tveten GM, Van Duppen P, Van de Walle J, Voulot D, Warr N, Wenander F, Wiens A, Wood JL, Zielińska M.

Phys Rev Lett. 2014 Apr 25;112(16):162701. Epub 2014 Apr 23.

PMID:
24815644
35.

Evidence for age-related performance degradation of (241)Am foil sources commonly used in UK schools.

Whitcher R, Page RD, Cole PR.

J Radiol Prot. 2014 Jun;34(2):347-61. doi: 10.1088/0952-4746/34/2/347. Epub 2014 Apr 4.

PMID:
24705303
36.

Blurring the boundaries: decays of multiparticle isomers at the proton drip line.

Carroll RJ, Page RD, Joss DT, Uusitalo J, Darby IG, Andgren K, Cederwall B, Eeckhaudt S, Grahn T, Gray-Jones C, Greenlees PT, Hadinia B, Jones PM, Julin R, Juutinen S, Leino M, Leppänen AP, Nyman M, O'Donnell D, Pakarinen J, Rahkila P, Sandzelius M, Sarén J, Scholey C, Seweryniak D, Simpson J.

Phys Rev Lett. 2014 Mar 7;112(9):092501. Epub 2014 Mar 4.

PMID:
24655248
37.

Size of metastatic deposits affects prognosis in patients undergoing pulmonary metastectomy for colorectal cancer.

Javed MA, Sheel AR, Sheikh AA, Page RD, Rooney PS.

Ann R Coll Surg Engl. 2014 Jan;96(1):32-6. doi: 10.1308/003588414X13824511650371.

38.

Giant pulmonary hamartoma causing acute right heart failure.

Joshi HM, Page RD.

Ann Thorac Surg. 2014 Jan;97(1):e21-2. doi: 10.1016/j.athoracsur.2013.07.099.

PMID:
24384217
39.

Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

Hirsh V, Okamoto I, Hon JK, Page RD, Orsini J, Sakai H, Zhang H, Renschler MF, Socinski MA.

J Thorac Oncol. 2014 Jan;9(1):83-90. doi: 10.1097/JTO.0000000000000011.

40.

BioNames: linking taxonomy, texts, and trees.

Page RD.

PeerJ. 2013 Oct 29;1:e190. doi: 10.7717/peerj.190. eCollection 2013.

41.

Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer.

Socinski MA, Okamoto I, Hon JK, Hirsh V, Dakhil SR, Page RD, Orsini J, Yamamoto N, Zhang H, Renschler MF.

Ann Oncol. 2013 Sep;24(9):2390-6. doi: 10.1093/annonc/mdt235. Epub 2013 Jul 10.

PMID:
23842283
42.

Signatures of the Z = 82 shell closure in α-decay process.

Andreyev AN, Huyse M, Van Duppen P, Qi C, Liotta RJ, Antalic S, Ackermann D, Franchoo S, Heßberger FP, Hofmann S, Kojouharov I, Kindler B, Kuusiniemi P, Lesher SR, Lommel B, Mann R, Nishio K, Page RD, Streicher B, Šáro Š, Sulignano B, Wiseman D, Wyss RA.

Phys Rev Lett. 2013 Jun 14;110(24):242502. Epub 2013 Jun 10.

PMID:
25165917
43.

The impact of positive circumferential margin on survival following oesophagectomy using the new 7th TNM classification.

Theologou T, Diab M, Kyaw PA, Gosney JR, McShane J, Howes N, Page RD, Shackcloth M.

Eur J Cardiothorac Surg. 2013 Nov;44(5):855-9. doi: 10.1093/ejcts/ezt164. Epub 2013 May 5.

PMID:
23650023
44.

Prophylaxis of chylothorax after esophagectomy.

Sheel AR, Page RD.

Ann Thorac Surg. 2013 Jan;95(1):387. doi: 10.1016/j.athoracsur.2012.06.038. Epub 2012 Dec 25. No abstract available.

PMID:
23272882
45.

Phenylephrine infusion improves blood flow to the stomach during oesophagectomy in the presence of a thoracic epidural analgesia.

Pathak D, Pennefather SH, Russell GN, Al Rawi O, Dave IC, Gilby S, Page RD.

Eur J Cardiothorac Surg. 2013 Jul;44(1):130-3. doi: 10.1093/ejcts/ezs644. Epub 2012 Dec 13.

PMID:
23242988
46.

Routine endoscopy to detect anastomotic leakage after esophagectomy.

Page RD, Asmat A, McShane J, Russell GN, Pennefather SH.

Ann Thorac Surg. 2013 Jan;95(1):292-8. doi: 10.1016/j.athoracsur.2012.09.048. Epub 2012 Nov 28.

PMID:
23200235
47.

Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.

Socinski MA, Langer CJ, Okamoto I, Hon JK, Hirsh V, Dakhil SR, Page RD, Orsini J, Zhang H, Renschler MF.

Ann Oncol. 2013 Feb;24(2):314-21. doi: 10.1093/annonc/mds461. Epub 2012 Nov 2.

PMID:
23123509
48.

Space, time, form: viewing the Tree of Life.

Page RD.

Trends Ecol Evol. 2012 Feb;27(2):113-20. doi: 10.1016/j.tree.2011.12.002. Epub 2011 Dec 29. Review.

PMID:
22209094
49.

Evolutionary informatics: unifying knowledge about the diversity of life.

Parr CS, Guralnick R, Cellinese N, Page RD.

Trends Ecol Evol. 2012 Feb;27(2):94-103. doi: 10.1016/j.tree.2011.11.001. Epub 2011 Dec 10. Review. Erratum in: Trends Ecol Evol. 2012 Jul;27(7):414.

PMID:
22154516
50.

Aggregating, tagging and integrating biodiversity research.

Mindell DP, Fisher BL, Roopnarine P, Eisen J, Mace GM, Page RD, Pyle RL.

PLoS One. 2011;6(8):e19491. doi: 10.1371/journal.pone.0019491. Epub 2011 Aug 1. No abstract available.

Supplemental Content

Support Center